TY  - JOUR

T1  - Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE).

JO  - Journal of Clinical Oncology

PY  - 2020/02/20

AU  - Hussain SA

AU  - Lester JF

AU  - Jackson R

AU  - Gornall M

AU  - Elliott A

AU  - Crabb SJ

AU  - Huddart RA

AU  - Vasudev N

AU  - Birtle AJ

AU  - Worlding J

AU  - James ND et al

ED  - 

DO  - DOI: 10.1200/jco.2020.38.6_suppl.438

PB  - American Society of Clinical Oncology (ASCO)

VL  - 38

IS  - 6_suppl

SP  - 438

EP  - 438

Y2  - 2024/12/22

ER  -